Archive

2008

Joslin Research Finds Nearly Three-quarters of Youths with Diabetes Insufficient in Vitamin D: BOSTON – Dec. 15, 2008 – Three-quarters of youths with type 1 diabetes were found to have insufficient levels of vitamin D, according to a study by researchers at the Joslin Diabetes Center – findings that suggest children with the disease may need vitamin D supplementation to prevent bone fragility later in life.
Joslin Research Links Genetic Variant, Poor Glycemic Control to Coronary Artery Disease: BOSTON – November 25, 2008 – A new study led by researchers at the Joslin Diabetes Center and Harvard Medical School has found that a common genetic variant associated with an increased risk of coronary artery disease (CAD) in the general population is also linked to an even higher risk for people with diabetes, particularly those with poor glucose control.
Joslin Researchers Identify New Source of Insulin-Producing Cells: BOSTON – Nov. 24, 2008 – Researchers at the Joslin Diabetes Center have shown that insulin-producing pancreatic beta cells can form after birth or after injury from progenitor cells within the pancreas that were not beta cells, a finding that contradicts a widely-cited earlier study that had concluded this is not possible.
Joslin Researcher Named First Winner of the Manpei Suzuki International Prize for Diabetes Research: BOSTON – November 6, 2008 – Joslin Diabetes Center today announced that C. Ronald Kahn, M.D., Head of the Joslin Section on Obesity and Hormone Action and the Mary K. Iacocca Professor of Medicine at Harvard Medical School, has been named the first winner of the Manpei Suzuki International Prize for Diabetes Research.
Joslin Diabetes Center Receives $3 million from Eli Lilly and Company Foundation for Obesity Studies: BOSTON – October 14, 2008 – Joslin Diabetes Center today announced it has received a three-year, $3 million grant from the Eli Lilly and Company Foundation to help fund studies that will investigate the underlying causes of obesity and insulin resistance – two leading risk factors for diabetes and heart disease. The donation is one of the largest in Joslin’s history.
Joslin Launches Unique Social Networking, Performance Improvement and Learning Initiative for Primary Care Physicians: BOSTON – September 23, 2008 – Joslin Diabetes Center today announced the introduction of the Joslin Professional Education Consortium (JPEC), a unique, comprehensive, Web-based resource and community for primary care physicians (PCPs) focused on treating diabetes and its complications. JPEC offers free, 24/7 social networking among peers and colleagues and access to support and education to improve patient care for diabetes and is designed to supplement continuing medical education (CME) activities.
Novel Short-Term Weight-Loss Approach Works Long-Term for Type 2 Diabetes: BOSTON – Sept. 2, 2008 – A study by researchers from the Joslin Diabetes Center has shown for the first time that more than half of patients with type 2 diabetes who enrolled in a novel short-term weight management program were able to maintain the weight loss they achieved during the program on their own long-term.
Joslin Diabetes Center Statement: Reported Possible Link between Byetta and Pancreatitis: BOSTON - Aug. 28, 2008 - The FDA recently issued an alert regarding several cases of severe pancreatitis, including two deaths from the condition and four deaths in individuals who had previously had pancreatitis, possibly associated with Byetta treatment for type 2 diabetes.
Joslin Study Identifies Protein that Produces ‘Good’ Fat: BOSTON – Aug. 20, 2008 – A study by researchers at the Joslin Diabetes Center has shown that a protein known for its role in inducing bone growth can also help promote the development of brown fat, a “good” fat that helps in the expenditure of energy and plays a role in fighting obesity.
Joslin Study Finds Insulin Resistance Causes Gallstones: BOSTON – July 22, 2008 – It has been known for more than 100 years that gallstones are more common in obese individuals. Now, researchers at the Joslin Diabetes Center have determined that insulin resistance is likely the reason why.
Joslin Diabetes Center Publishes Staying Healthy with Diabetes: Weight & Wellness: BOSTON – July 15, 2008 – Joslin Diabetes Center today announced the release of Staying Healthy with Diabetes: Weight & Wellness, the latest book in its popular "Staying Healthy with Diabetes" series. Written for consumers, Weight & Wellness provides information and strategies to help individuals with type 2 diabetes achieve a healthy weight and maintain it over time.
Muscle Stem Cell Transplant Boosts Diseased Muscle Function and Replenishes Stem Cell Pool: BOSTON – July 10, 2008 – Researchers at the Joslin Diabetes Center have demonstrated for the first time that transplanted muscle stem cells can both improve muscle function in animals with a form of muscular dystrophy and replenish the stem cell population for use in the repair of future muscle injuries.
Dietary Adherence Associated with Better Glucose Control in Children with Type 1 Diabetes: BOSTON – July 1, 2008 – A study by researchers at the Joslin Diabetes Center has shown that adherence to prescribed dietary recommendations is associated with better glucose control in children with type 1 diabetes.
Joslin Diabetes Center and Epocrates Launch Innovative Diabetes Resource for Clinicians: BOSTON – June 18, 2008 – Clinicians across America now have access to the knowledge and opinions of a renowned diabetes expert, thanks to a collaboration between Joslin Diabetes Center, the world’s largest diabetes clinic, research center and provider of diabetes education, and Epocrates Inc., a leading developer of handheld clinical applications.
Massachusetts Governor Deval Patrick Signs Historic Life Sciences Bill at Joslin Diabetes Center: BOSTON - June 16, 2008 - Today, Joslin Diabetes Center hosted Massachusetts Governor Deval Patrick, legislative leaders and other distinguished guests for the signing of the historic Life Sciences Law , a $1 billion, 10-year initiative.
Beta Cell Defect Linked to Type 2 Diabetes: SAN FRANCISCO – June 8, 2008 – Scientists at the Joslin Diabetes Center in Boston have found that a defect in the beta cells that make and release insulin has implications for the failure of these cells and the development of type 2 diabetes.
Study Finds Individuals with Long-Term Type 1 Diabetes Still Capable of Producing Insulin: SAN FRANCISCO – June 8, 2008 – Researchers at the Joslin Diabetes Center in Boston have discovered that a significant portion of people who have had type 1 diabetes for 50 or more years still have the capacity to produce insulin, a finding that has potential implications for improved treatment for all with the disease.
Joslin Study Shows Short-Term Weight Loss Program Works Long-Term: SAN FRANCISCO – June 7, 2008 – Researchers from the Joslin Diabetes Center in Boston have shown for the first time that patients with diabetes who enrolled in a short-term weight management program were able to maintain the weight loss they achieved during the program on their own long-term.
Joslin Diabetes Center and Sunstar Inc. Announce Education Initiative: BOSTON -- June 2, 2008 – Joslin Diabetes Center and Sunstar Inc., a Japanese maker of oral health and nutritional products, have teamed up to launch an initiative aimed at educating dentists and physicians about the link between diabetes and gum disease and other oral health issues, as well as the significance of nutrition to each.
Joslin Study Finds Anti-inflammatory Medication May Treat Type 2 Diabetes: BOSTON – May 21, 2008 -- Researchers at the Joslin Diabetes Center who reported earlier this year that an inexpensive, non-steroidal anti-inflammatory drug called salsalate might prevent type 2 diabetes are now reporting that the drug may also be beneficial in the treatment of the disease.
Not All Fat Created Equal: BOSTON – May 6, 2008 -- It has long been known that type 2 diabetes is linked to obesity, particularly fat inside the belly. Now, researchers at the Joslin Diabetes Center have found that fat from other areas of the body can actually reduce insulin resistance and improve insulin sensitivity.
Team Joslin Running Marathon in Boston with High Hopes for Diabetes Cure: BOSTON – April 14, 2008 -- Running a marathon takes skill, dedication and tremendous athleticism. This year, 13 motivated individuals will hit the ground running on April 21 as part of Team Joslin in the Boston Marathon. They will make the trek from Hopkinton to Boston in support of the Joslin Diabetes Center’s High Hopes Fund which supports the Center's efforts to improve the lives of people with diabetes through care, education and research, and to prevent and cure the disease.
Joslin Study Identifies Gene Involved in Blood Stem Cell Replication, Movement: BOSTON – April 9, 2008 -- Researchers at the Joslin Diabetes Center have identified a gene that is responsible for the division and movement of marrow-derived, blood-forming stem cells, a finding that could have major implications for the future of bone marrow and blood cell transplantation.
Joslin Researchers Discover New Effect for Insulin: BOSTON – March 20, 2008 - Researchers at the Joslin Diabetes Center have shown that insulin has a previously unknown effect that plays a role in aging and lifespan, a finding that could ultimately provide a mechanism for gene manipulations that could help people live longer and healthier lives.
Joslin Diabetes Center Updates Diabetes Deskbook: BOSTON – March 10, 2008 – Joslin Diabetes Center today announced the release of the Second Edition of its comprehensive resource Joslin’s Diabetes Deskbook – A Guide for Primary Care Providers.
Overweight Hispanic Children Shown to Have Vascular Inflammation: BOSTON - Feb. 27, 2008 -- Overweight Hispanic children with normal blood glucose (sugar) levels showed elevated markers for blood vessel inflammation that may predispose them to developing both type 2 diabetes and cardiovascular disease, says a new study led by researchers from the Joslin Diabetes Center.
Joslin Study Finds Restricting Insulin Doses Increases Mortality Risk : BOSTON – Feb. 27, 2008 -- A new study led by researchers at the Joslin Diabetes Center has found that women with type 1 diabetes who reported taking less insulin than prescribed had a three-fold increased risk of death and higher rates of disease complications than those who did not skip needed insulin shots.
Joslin Diabetes Center and The Barton Center for Diabetes Education Reach Agreement for Barton to Manage Camp Joslin : OXFORD, Mass., Feb. 25, 2008 – The Barton Center for Diabetes Education, Inc. and the Joslin Diabetes Center announced today that The Barton Center will manage and operate Camp Joslin in Charlton, Mass. Under the agreement, The Barton Center assumes responsibility for all management and operations of Camp Joslin. Joslin retains ownership of Camp Joslin.
Michael P. Sullivan Joins Joslin Diabetes Center As Senior Vice President Of Development: February 13, 2008 – Joslin Diabetes Center today announced Michael P. Sullivan of Boston as senior vice president of development. Sullivan comes to Joslin from a successful program at Spaulding Rehabilitation Hospital Network, with deep ties to the Greater Boston community and a strong track record in healthcare philanthropy, public affairs and government.
Joslin Diabetes Center Statement: ACCORD Study : BOSTON -- February 6, 2008 -- Today, the National Heart, Lung, and Blood Institute announced that it has halted the intensive blood glucose (sugar) control arm in one of its studies due to safety concerns.
Joslin Study Identifies Key Factor that Links Metabolic Syndrome: BOSTON – Feb. 5, 2008 -- A new study led by researchers at Joslin Diabetes Center has identified insulin resistance in the liver as a key factor in the cause of metabolic syndrome and its associated atherosclerosis, disorders that put tens of millions of Americans at high risk of cardiovascular disease.
Joslin Study Shows Anti-Inflammatory Drug May Prevent Type 2 Diabetes: BOSTON – Jan. 28, 2008 -- Researchers at the Joslin Diabetes Center are reporting that an inexpensive anti-inflammatory drug similar to aspirin, salsalate, may prevent type 2 diabetes by lowering blood glucose and reducing inflammation.

Page last updated: November 18, 2018